Environmental Toxins from Superpower

Superpower identifies a single morning urine specimen and LC-MS/MS with creatinine normalization by Jaffe reaction under CLIA number 17D0919496. The performing laboratory name and complete precision, accuracy, detection-limit, quality-control, and offer-level validation data are not published.

The panel measures urinary metabolites of common environmental chemicals to establish a recent exposure baseline. Superpower states that results do not identify the exact exposure source, predict future harm, prove toxicity, or diagnose a condition.

The exact offer names 27 markers across phthalates, bisphenols, parabens, pesticides and herbicides, volatile organic compounds, and other environmental markers. Heavy metals and mold toxins require separate panels, so this is broad chemical-exposure coverage rather than a complete environmental assessment.

Results include measured levels, laboratory reference-range comparisons, likely source categories for elevated markers, dashboard delivery, an updated Action Plan, and care-team or AI-concierge support. Reference ranges vary by laboratory and the page says results require clinical context.

The offer publishes the test price, separate membership charge, specimen, method, 27-marker scope, preparation, turnaround, state availability, payment caveat, and non-diagnostic boundary. It does not name the performing laboratory or publish complete analytical performance data.

Collection uses one first-morning urine sample at home with no fasting, blood draw, or clinic visit, followed by prepaid mail return and results typically within 10 days of laboratory receipt. The offer is available in 40 named jurisdictions and excludes New York and New Jersey.

The current offer lists a $399 test charge plus a separate $349 annual membership, for $748 before any other applicable charges. The membership agreement specifically makes the Environmental Toxins Panel non-refundable, while HSA or FSA acceptance depends on the buyer's plan.

Superpower provides access, correction, deletion, portability, and opt-out rights, but permits disclosure to affiliated providers, service and diagnostic partners, marketing partners, authorities, and transaction counterparties. It may use or sell de-identified data, and neither an exact retention period nor a product-specific specimen-destruction schedule is published.